Foghorn Therapeutics, Inc.
Our corporate headquarters is in Cambridge, Massachusetts.
The Company is incorporated in Delaware.
Foghorn Therapeutics stock was listed on the NASDAQ Global Market under the ticker symbol FHTX. The Company’s Initial Public Offering was priced on 10/22/2020.
Foghorn Therapeutics fiscal year ends December 31st.
Ropes & Gray
800 Boylston Street
Boston, Massachusetts 02199
Deloitte & Touche LLP
200 Berkeley Street
Boston, Massachusetts 02116
150 Royal Street
Canton, Massachusetts 02021
For questions about your stock please contact our transfer agent, Computershare Trust Company, N.A.
Shares of Foghorn Therapeutics can be purchased through a securities broker of your choosing.
Please contact email@example.com at Foghorn Therapeutics for any additional Investor inquiries.
Company filings can be accessed via the SEC’s website by searching for
CIK Code: 0001822462
CUSIP number: 344174107
Please visit Foghorn Therapeutics’ website at www.foghorntx.com.